One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
https://doi.org/10.1200/jco.2014.32.15_suppl.tps8624
Copy DOI
Export
Save
Share
Cite Journal: Journal of Clinical Oncology |  Publication Date: May 20, 2014 |
 Citations: 4 |
Affiliation: Carolinas Healthcare System, The University of Texas MD Anderson Cancer Center, University of Chicago, Yale Cancer Center, International Myeloma Foundation, Mayo Clinic, Dana-Farber Cancer Institute, USC Norris Cancer Hospital, University of Southern California, Massachusetts General Hospital, Cancer Research And Biostatistics, SWOG Cancer Research Network, Karmanos Cancer Institute
TPS8624 Background: The introduction of immunomodulatory agents and proteasome inhibitors, and advances in high dose therapy administration have made an impact on progression free survival (PFS) an...
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
